<DOC>
	<DOCNO>NCT03075891</DOCNO>
	<brief_summary>The main objective study evaluate efficacy Ivermectin 1 % topical cream associate Doxycycline 40 mg Modified release ( MR ) capsule versus Ivermectin 1 % topical cream associate Placebo treatment severe Rosacea .</brief_summary>
	<brief_title>Oracea Soolantra Association Patients With Severe Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Ivermectin</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Male female subject age â‰¥ 18 year old ; Subject minimum 20 70 inflammatory lesion ( papule pustule ) rosacea face Baseline visit ; Subject severe rosacea papulopustular lesion ( accord Investigator 's Global Assessment , IGA score rat 4 ) ; Female subject childbearing potential negative urine pregnancy test ( UPT ) ; Female subject childbearing potential must practice highly effective method contraception study ; Subjects particular form rosacea concomitant facial dermatosis may confound rosacea ; Subjects 2 nodule rosacea face ; Subjects uncontrolled chronic serious disease medical condition may either interfere interpretation clinical trial result , optimal participation study would present significant risk subject ; Subjects know suspected allergy sensitivity component investigational noninvestigational product , include active ingredient doxycycline ivermectin ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>